* Rapid Micro Biosystems Inc RPID.OQ reported a quarterly
adjusted loss of 31 cents per share for the quarter ended in
September, higher than the same quarter last year, when the
company reported EPS of -38 cents. The mean expectation of
three analysts for the quarter was for a loss of 31 cents per
share. Wall Street expected results to range from -32 cents
to -28 cents per share.
* Revenue rose 29.7% to $6.15 million from a year ago;
analysts
expected $5.55 million.
* Rapid Micro Biosystems Inc's reported EPS for the quarter
was a
loss of 31 cents.
* The company reported a quarterly loss of $13.39 million.
* Rapid Micro Biosystems Inc shares had fallen by 6.0% this
quarter and lost 10.2% so far this year.
FORECAST CHANGES
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
RECOMMENDATIONS
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."
* The average consensus recommendation for the
pharmaceuticals
peer group is also "buy"
Wall Street's median 12-month price target for Rapid Micro
Biosystems Inc is $5.88
This summary was machine generated from LSEG data November 3 at
08:31 p.m. UTC. All figures in US dollars unless otherwise
stated. QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Sep. 30 2023 -0.31 -0.31 Met
Jun. 30 2023 -0.35 -0.33 Beat
Mar. 31 2023 -0.36 -0.32 Beat
Dec. 31 2022 -0.36 -0.39 Missed